IndraLab

Statements

Hydroxychloroquine inhibits histone deacetylase inhibitor. 4 / 4
| 4
reach
"For example, HCQ has been reported to enhance the anticancer activity of the histone deacetylase inhibitor, vorinostat (VOR), in pre-clinical models and early phase clinical studies of metastatic colorectal cancer (mCRC) (Patel et al., 2016)."
| DOI
reach
"For example, HCQ has been reported to enhance the anti-cancer activity of the histone deacetylase inhibitor, vorinostat (VOR), in pre-clinical models and early phase clinical studies of metastatic colorectal cancer (mCRC) [75]."
34181666
reach
"In support of the role of autophagy in modulating response to treatment, the administration of hydroxychloroquine (HCQ), an autophagy inhibitor, was found to enhance anti-cancer activity of the histone deacetylase inhibitor, vorinostat (VOR), in preclinical models and early phase clinical studies of metastatic CRC [XREF_BIBR]."
| PMC
reach
"Hydroxychloroquine (HCQ) enhances the anti-cancer activity of the histone deacetylase inhibitor, vorinostat (VOR), in pre-clinical models and early phase clinical studies of metastatic colorectal cancer (mCRC)."
27463016